top of page

Mycotoxins 
Analytes of Interest

large-aflatoxin
Cannabis Leaf
Cannabis Leaf

Aflatoxins, including B1, B2, G1, and G2, are highly toxic mycotoxins produced by certain molds, particularly Aspergillus species, commonly found in agricultural products such as cannabis. These toxins are potent carcinogens and can cause liver damage, immune suppression, and developmental issues in humans.

 

Aflatoxin B1, in particular, is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), indicating it poses a significant risk of causing cancer in humans. Aflatoxins have been associated with liver cancer, acute aflatoxicosis, and other health problems, making strict regulation and monitoring essential to mitigate health risks associated with cannabis consumption.

Similarly, Ochratoxin A is a mycotoxin produced by molds, such as Aspergillus and Penicillium species, and is commonly found in cannabis and other agricultural products. Ochratoxin A is known for its nephrotoxic and carcinogenic effects, particularly its association with kidney damage and increased risk of kidney cancer.

 

Chronic exposure to Ochratoxin A has also been linked to other health issues, including immune system suppression and developmental abnormalities. Therefore, rigorous testing and adherence to regulatory limits for Ochratoxin A in cannabis products are crucial for ensuring consumer safety and mitigating the risks of adverse health effects.

Aflatoxin B1 (AFB1)

Aflatoxin B1 (AFB1) is a toxic substance made by molds that can grow on cannabis plants. If someone consumes cannabis contaminated with AFB1, it can damage their liver and may even cause liver cancer over time. Scientists use special tests to find AFB1 in cannabis to make sure it's safe for people to use.

Aflatoxin_B1

Analyte of Interest

Aflatoxin B1 (AFB1) is a highly toxic and carcinogenic mycotoxin produced primarily by Aspergillus flavus and Aspergillus parasiticus fungi. It is considered one of the most potent naturally occurring carcinogens, known to cause liver cancer in humans and animals upon chronic exposure. AFB1 exerts its carcinogenic effects by forming DNA adducts, which can lead to mutations in liver cells and subsequent tumor formation.

 

Inhalation or ingestion of cannabis contaminated with AFB1 poses a significant health risk to consumers, particularly concerning liver health and cancer development. Even at relatively low levels, chronic exposure to AFB1 can result in severe liver damage and increase the risk of hepatocellular carcinoma.

Due to its high toxicity and carcinogenic potential, regulatory agencies impose strict limits on AFB1 levels in food and agricultural products, including cannabis. Stringent testing protocols are essential to detect and quantify AFB1 contamination in cannabis products, ensuring compliance with safety regulations and protecting consumer health.

 

Cannabis laboratories utilize advanced analytical techniques such as high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LC-MS) to accurately measure AFB1 levels in cannabis samples. By implementing rigorous testing measures, cannabis producers and manufacturers can mitigate the risk of AFB1 contamination and safeguard the health and safety of consumers.

Aflatoxin B2 (AFB2)

Aflatoxin B2 (AFB2) is a harmful substance produced by molds that can grow on cannabis plants. When people consume cannabis contaminated with AFB2, it can damage their liver and increase the risk of developing liver cancer. Scientists use special tests to detect AFB2 in cannabis to ensure it's safe for people to use.

Aflatoxin_B2

Analyte of Interest

Aflatoxin B2 (AFB2) is a mycotoxin produced by certain species of Aspergillus fungi, particularly Aspergillus flavus and Aspergillus parasiticus. While AFB2 is considered less potent than its counterpart Aflatoxin B1 (AFB1), it still poses significant health risks upon chronic exposure. Like AFB1, AFB2 exerts its carcinogenic effects primarily in the liver, where it can lead to liver damage and an increased risk of liver cancer. The mechanism of action involves the formation of DNA adducts, which can induce mutations in liver cells, contributing to tumor formation over time.

Consumption of cannabis contaminated with AFB2 presents a notable health risk to consumers, particularly concerning liver health and cancer development. Inhalation or ingestion of AFB2-contaminated cannabis products can introduce the toxin into the body, where it may accumulate and exert its harmful effects on liver function. Despite being less potent than AFB1, chronic exposure to AFB2 still warrants significant concern due to its potential to cause liver damage and cancer.

Therefore, stringent testing protocols are essential to detect and limit the presence of AFB2 in cannabis products, ensuring consumer safety and regulatory compliance. By implementing rigorous testing measures, cannabis laboratories can identify and quantify AFB2 levels, thereby mitigating the risk of exposure to this carcinogenic mycotoxin. Ultimately, the thorough screening of cannabis products for AFB2 is crucial for safeguarding public health and ensuring the safety of consumers.

Aflatoxin G1 (AFG1)

Aflatoxin G1 (AFG1) is a toxic substance made by molds that can grow on cannabis plants. If someone consumes cannabis contaminated with AFG1, it can hurt their liver and may even cause liver cancer over time. Scientists use special tests to find AFG1 in cannabis to make sure it's safe for people to use.

Aflatoxin_G1

Analyte of Interest

Aflatoxin G1 (AFG1) is a potent mycotoxin produced by certain species of fungi, particularly Aspergillus flavus and Aspergillus parasiticus. Like its counterpart Aflatoxin B1 (AFB1), AFG1 is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), indicating its high carcinogenicity and potential to cause cancer in humans. AFG1 is formed as a result of fungal contamination in agricultural commodities, including cannabis, and is commonly found alongside other aflatoxins such as AFB1 and Aflatoxin G2 (AFG2).

Upon ingestion or inhalation, AFG1 can exert its toxic effects primarily on the liver, leading to hepatotoxicity and an increased risk of hepatocellular carcinoma (liver cancer). The mechanism of action involves the formation of DNA adducts, which can induce mutations in liver cells and disrupt cellular functions, ultimately contributing to tumor initiation and progression. Chronic exposure to AFG1 through the consumption of contaminated cannabis products can result in severe liver damage and long-term health consequences.

Due to its potent carcinogenic properties, AFG1 is subject to regulatory scrutiny, and strict limits are imposed on its levels in food and agricultural products, including cannabis. Comprehensive testing protocols utilizing advanced analytical techniques such as high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LC-MS) are employed to detect and quantify AFG1 contamination in cannabis samples. By implementing stringent testing measures, cannabis producers and manufacturers can ensure compliance with safety regulations and mitigate the risk of AFG1 exposure, thereby safeguarding the health and well-being of consumers.

Aflatoxin G2 (AFG2)

Aflatoxin G2 (AFG2) is a type of poisonous substance produced by certain molds, like Aspergillus flavus and Aspergillus parasiticus, which can grow on cannabis plants. If people consume cannabis contaminated with AFG2, it can harm their liver and increase the chances of getting liver cancer. Scientists check cannabis for AFG2 using special tests to make sure it's safe for people to use.

Aflatoxin_G2

Analyte of Interest

Aflatoxin G2 (AFG2) is a highly toxic mycotoxin produced by certain species of fungi, particularly Aspergillus flavus and Aspergillus parasiticus. Alongside Aflatoxin B1 (AFB1) and Aflatoxin G1 (AFG1), AFG2 is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), indicating its high carcinogenicity and potential to cause cancer in humans. AFG2 is formed as a result of fungal contamination in agricultural commodities, including cannabis, and is commonly found alongside other aflatoxins.

Upon ingestion or inhalation, AFG2 can exert its toxic effects primarily on the liver, leading to hepatotoxicity and an increased risk of hepatocellular carcinoma (liver cancer). Similar to other aflatoxins, the carcinogenic mechanism of AFG2 involves the formation of DNA adducts, which can induce mutations in liver cells and disrupt cellular functions, ultimately contributing to tumor initiation and progression. Chronic exposure to AFG2 through the consumption of contaminated cannabis products can result in severe liver damage and long-term health consequences.

Due to its potent carcinogenic properties, AFG2 is subject to regulatory scrutiny, and strict limits are imposed on its levels in food and agricultural products, including cannabis. Comprehensive testing protocols utilizing advanced analytical techniques such as high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LC-MS) are employed to detect and quantify AFG2 contamination in cannabis samples. By implementing stringent testing measures, cannabis producers and manufacturers can ensure compliance with safety regulations and mitigate the risk of AFG2 exposure, thereby safeguarding the health and well-being of consumers.

Ochratoxin A (OTA)

Ochratoxin A (OTA) is a harmful substance found in certain fungi that can grow on cannabis plants. When consumed, it can cause kidney damage and might even lead to cancer over time. Scientists use special tools to detect OTA in cannabis to keep people safe from its harmful effects.

Ochratoxin_A

Analyte of Interest

Ochratoxin A (OTA) is a toxic secondary metabolite produced by various fungal species, including Aspergillus and Penicillium genera. It is one of the most prevalent mycotoxins found in agricultural commodities, including cereals, nuts, and dried fruits, as well as cannabis. OTA poses significant health risks to humans and animals due to its nephrotoxic, carcinogenic, and immunotoxic properties.

Upon ingestion or inhalation, OTA can exert its toxic effects primarily on the kidneys, leading to nephrotoxicity and potentially resulting in chronic kidney disease and renal carcinoma. OTA is also classified as a possible carcinogen by the International Agency for Research on Cancer (IARC), indicating its potential to cause cancer in humans. Additionally, OTA has been associated with immunosuppression, which can compromise the body's ability to fight infections and other diseases.

The mechanism of OTA toxicity involves its ability to inhibit protein synthesis and induce oxidative stress, leading to cellular damage and dysfunction. OTA can accumulate in various tissues and organs, including the kidneys and liver, upon chronic exposure, exacerbating its toxic effects over time. While the exact levels of OTA contamination in cannabis products may vary, stringent testing protocols are essential to detect and quantify OTA levels accurately.

Cannabis laboratories utilize advanced analytical techniques such as high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LC-MS) to analyze cannabis samples for OTA contamination. By implementing rigorous testing measures, cannabis producers and manufacturers can ensure compliance with safety regulations and mitigate the risk of OTA exposure, thereby safeguarding the health and well-being of consumers.

bottom of page